University of Cambridge Enterprise Fund VI Overview
- Fund Type
-
Venture
- Fund Status
-
Fully Invested
- Fund Manager
- Parkwalk Advisor...
- Vintage
-
2018
- Dry Powder
-
University of Cambridge Enterprise Fund VI General Information
Description
University of Cambridge Enterprise Fund VI is a 2018 vintage early-stage venture capital fund managed by Parkwalk Advisors. The fund is located in London, England, and invested in the United Kingdom. The fund targeted TMT, advanced manufacturing, big data, cleantech, construction technology, infrastructure, life sciences, and nanotechnology sectors in the United Kingdom. The fund targeted impact investment related to energy, education, and health.
Contact Information
Fund Manager's Location
- 3 Pancras Square
- Kings Cross
- London N1C 4AG
- England, United Kingdom
University of Cambridge Enterprise Fund VI Investments (10)
University of Cambridge Enterprise Fund VI has made a total of 10 investments. Its most recent deal was a with Porotech for . The deal was made on 13-May-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Porotech | 13-May-2020 | General Purpose Semiconductors | Generating Revenue | |||
| PharmEnable Therapeutics | 28-Apr-2020 | Drug Discovery | Generating Revenue | |||
| Kalium Health | 21-Feb-2020 | Monitoring Equipment | Startup | |||
| DIOSynVax | 31-Jan-2020 | Biotechnology | Generating Revenue | |||
| Cambridge Photon Technology | 24-Jan-2020 | Alternative Energy Equipment | Generating Revenue | |||
| Xampla | 15-Jan-2020 | Other Commercial Products | Startup | |||
| Cambridge GaN Devices | 21-Jun-2019 | Application Specific Semiconductors | Generating Revenue | |||
| Qkine | 01-May-2019 | Biotechnology | Generating Revenue | |||
| PolyProx Therapeutics | 01-Mar-2019 | Seed Round | Drug Discovery | Generating Revenue | ||
| Echion Technologies | 03-Dec-2018 | Seed Round | Other Materials | Generating Revenue |
University of Cambridge Enterprise Fund VI Investment Strategy
Investments by Industry
Investments by Deal Type
University of Cambridge Enterprise Fund VI Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
University of Cambridge Enterprise Fund VI FAQs
-
What is University of Cambridge Enterprise Fund VI?
University of Cambridge Enterprise Fund VI is a 2018 vintage early-stage venture capital fund managed by Parkwalk Advisors.
-
Who manages University of Cambridge Enterprise Fund VI?
University of Cambridge Enterprise Fund VI is managed by Parkwalk Advisors.
-
Where is University of Cambridge Enterprise Fund VI domiciled?
University of Cambridge Enterprise Fund VI is domiciled in United Kingdom.
-
What type of fund is University of Cambridge Enterprise Fund VI?
The fund type of University of Cambridge Enterprise Fund VI is Venture.
-
What is the status of University of Cambridge Enterprise Fund VI?
University of Cambridge Enterprise Fund VI is fully invested.
-
What has University of Cambridge Enterprise Fund VI invested in?
University of Cambridge Enterprise Fund VI has made numerous investments in companies like Porotech, PharmEnable Therapeutics, and Kalium Health within the General Purpose Semiconductors, Drug Discovery, and Monitoring Equipment industries.
-
What has University of Cambridge Enterprise Fund VI invested in recently?
University of Cambridge Enterprise Fund VI's latest investment was on 13-May-2020 in Porotech, a company within the General Purpose Semiconductors industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
